These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 10544324)

  • 21. Health insurance--a challenge in India.
    Presswala RG
    J Insur Med; 2004; 36(1):60-73. PubMed ID: 15104031
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lifetime cover in private insurance markets.
    Brown HS; Connelly LB
    Int J Health Care Finance Econ; 2005 Mar; 5(1):75-88. PubMed ID: 15714264
    [TBL] [Abstract][Full Text] [Related]  

  • 23. How can we prevent cream skimming in a competitive health insurance market? The great challenge for the 90's.
    Van de Ven WP; Van Vliet RC
    Dev Health Econ Public Policy; 1992; 1():23-46. PubMed ID: 10151748
    [No Abstract]   [Full Text] [Related]  

  • 24. What kind of healthcare 'internal market'? A cross-Europe view of the options.
    Sheaff R
    Int J Health Plann Manage; 1994; 9(1):5-24. PubMed ID: 10137133
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Theory of health insurance.
    Nyman JA
    J Health Adm Educ; 1998; 16(1):41-66. PubMed ID: 10185500
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Eating disorders and health insurance.
    Silber TJ
    Arch Pediatr Adolesc Med; 1994 Aug; 148(8):785-8. PubMed ID: 8044253
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Primary care: core values. Primary care in an imperfect market.
    Roberts J
    BMJ; 1998 Jul; 317(7152):186-9. PubMed ID: 9665903
    [No Abstract]   [Full Text] [Related]  

  • 28. Access to coverage for high-risks in a competitive individual health insurance market: via premium rate restrictions or risk-adjusted premium subsidies?
    van de Ven WP; van Vliet RC; Schut FT; van Barneveld EM
    J Health Econ; 2000 May; 19(3):311-39. PubMed ID: 10977194
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Health and the cost of nongroup insurance.
    Hadley J; Reschovsky JD
    Inquiry; 2003; 40(3):235-53. PubMed ID: 14680257
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interpreting Canada: models, mind-sets, and myths.
    Barer ML; Evans RG
    Health Aff (Millwood); 1992; 11(1):44-61. PubMed ID: 1445524
    [No Abstract]   [Full Text] [Related]  

  • 31. Everybody into the pool! Medicare in the twenty-first century.
    Poplin C
    J Health Soc Policy; 1997; 9(2):49-60. PubMed ID: 10174378
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk selection and complementary health insurance: the Swiss approach.
    Kifmann M
    Int J Health Care Finance Econ; 2006 Jun; 6(2):151-70. PubMed ID: 16783507
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comment on the Jackson Hole initiatives for a twenty-first century American health care system.
    Reinhardt UE
    Health Econ; 1993 Apr; 2(1):7-14. PubMed ID: 8269050
    [No Abstract]   [Full Text] [Related]  

  • 34. Price elasticities in the German Statutory Health Insurance market before and after the health care reform of 2009.
    Pendzialek JB; Danner M; Simic D; Stock S
    Health Policy; 2015 May; 119(5):654-63. PubMed ID: 25670009
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Managed care, market power, and monopsony.
    Pauly MV
    Health Serv Res; 1998 Dec; 33(5 Pt 2):1439-60. PubMed ID: 9865228
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Commentary--How consumer-driven health care evolves in a dynamic market.
    Scandlen G
    Health Serv Res; 2004 Aug; 39(4 Pt 2):1113-8. PubMed ID: 15230914
    [No Abstract]   [Full Text] [Related]  

  • 37. High cost pool or high cost groups-How to handle high(est) cost cases in a risk adjustment mechanism?
    Schillo S; Lux G; Wasem J; Buchner F
    Health Policy; 2016 Feb; 120(2):141-7. PubMed ID: 26806676
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Voluntary health insurance in the European Union: a critical assessment.
    Mossialos E; Thomson SM
    Int J Health Serv; 2002; 32(1):19-88. PubMed ID: 11915863
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Some observations about risk adjustment research.
    Dowd BE; Feldman R
    Inquiry; 2001; 38(3):315-8. PubMed ID: 11761359
    [No Abstract]   [Full Text] [Related]  

  • 40. A new prevention paradox: the trade-off between reducing incentives for risk selection and increasing the incentives for prevention for health insurers.
    Kanters TA; Brouwer WB; van Vliet RC; van Baal PH; Polder JJ
    Soc Sci Med; 2013 Jan; 76(1):150-8. PubMed ID: 23182593
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.